Gain Therapeutics Inc (GANX)
2.58
-0.11
(-4.09%)
USD |
NASDAQ |
May 17, 16:00
2.58
0.00 (0.00%)
After-Hours: 20:00
Gain Therapeutics Price: 2.58 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 16, 2024 | 2.62 | 2.83 | 2.58 | 2.69 | 128514.0 |
May 15, 2024 | 2.45 | 2.650 | 2.40 | 2.62 | 151643.0 |
May 14, 2024 | 2.57 | 2.580 | 2.34 | 2.34 | 240365.0 |
May 13, 2024 | 2.59 | 2.59 | 2.360 | 2.42 | 54674.00 |
May 10, 2024 | 2.70 | 2.70 | 2.41 | 2.51 | 106802.0 |
May 09, 2024 | 2.65 | 2.973 | 2.48 | 2.54 | 239414.0 |
May 08, 2024 | 2.86 | 2.98 | 2.65 | 2.68 | 202533.0 |
May 07, 2024 | 2.90 | 3.14 | 2.78 | 2.90 | 164588.0 |
May 06, 2024 | 2.99 | 3.025 | 2.82 | 2.85 | 131742.0 |
May 03, 2024 | 3.00 | 3.02 | 2.87 | 2.96 | 96022.00 |
May 02, 2024 | 3.01 | 3.059 | 2.87 | 2.93 | 121739.0 |
May 01, 2024 | 2.97 | 3.06 | 2.911 | 2.97 | 57800.00 |
Apr 30, 2024 | 2.97 | 3.00 | 2.88 | 2.93 | 34758.00 |
Apr 29, 2024 | 3.01 | 3.03 | 2.890 | 3.00 | 38570.00 |
Apr 26, 2024 | 3.09 | 3.18 | 2.887 | 3.03 | 179297.0 |
Apr 25, 2024 | 3.10 | 3.20 | 2.95 | 3.07 | 142421.0 |
Apr 24, 2024 | 3.54 | 3.65 | 3.12 | 3.19 | 146812.0 |
Apr 23, 2024 | 3.13 | 3.39 | 3.070 | 3.39 | 66437.00 |
Apr 22, 2024 | 3.27 | 3.43 | 3.12 | 3.17 | 53675.00 |
Apr 19, 2024 | 3.11 | 3.26 | 3.00 | 3.18 | 71353.00 |
Apr 18, 2024 | 3.19 | 3.32 | 3.10 | 3.15 | 78261.00 |
Apr 17, 2024 | 3.16 | 3.271 | 3.10 | 3.18 | 80646.00 |
Apr 16, 2024 | 3.10 | 3.19 | 2.925 | 3.16 | 111460.0 |
Apr 15, 2024 | 3.10 | 3.230 | 3.02 | 3.09 | 81897.00 |
Apr 12, 2024 | 3.262 | 3.323 | 3.01 | 3.15 | 124939.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.07
Minimum
Nov 21 2023
15.80
Maximum
Apr 05 2021
5.087
Average
4.032
Median
Price Benchmarks
Eli Lilly and Co | 770.79 |
Alpine Immune Sciences Inc | 65.00 |
Outlook Therapeutics Inc | 7.78 |
OptiNose Inc | 1.26 |
Greenwich LifeSciences Inc | 14.07 |
Price Related Metrics
PEG Ratio | -0.0486 |
Price to Book Value | 3.327 |
Earnings Yield | -66.28% |
Market Cap | 41.85M |
PEGY Ratio | -0.0486 |